Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PF-06747775: a third-generation EGFR tyrosine kinase inhibitor

March 16, 2016

ViDAC Pharma describes first-in-class VDAC/HK modulator for skin cancer

March 16, 2016

Novel dual-target compounds inhibit inducible nitric oxide synthase and cannabinoid CB1 receptors

March 16, 2016

Safety, tolerability and pharmacokinetics of LCB01-0371 in healthy volunteers

March 16, 2016

Dacomitinib evaluated in advanced or metastatic PSCC chemonaive patients

March 15, 2016

Lower TSPO expression may be a marker of poor prognosis in ACC

March 15, 2016

miR-26b may be useful as a prognostic biomarker in advanced breast cancer

March 15, 2016

Eli Lilly develops novel EP4 receptor antagonists

March 15, 2016

Efficacy of endoxifen in bipolar disorder

March 14, 2016

BMS reports data on BMS-986142

March 14, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026